INNATE IMMUNOTHERAPEUTICS LTD's ticker is and the CUSIP is ACI11Y0R8. A total of 1 filers reported holding INNATE IMMUNOTHERAPEUTICS LTD in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $26,000 | – | 450,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| QCI ASSET MANAGEMENT INC/NY | 450,000 | $26,000 | 0.00% |